Objective To explore the regularity of damage of anti-lipid peroxidation by air pollutants, and to provide experimental basis for revealing the pathogenetic mechanism of air pollutants. Methods 80 Wistar rats weighting 180-200 g were randomly and averagely divided into 4 groups, ie control group, lower dose group, middle dose group and higher dose group, which were exposed to particulate, SO2 and NO2 respectively. The rats in lower dose group, middle dose group and higher dose group were perfused by 1 ml normal saline mixed with 7.5, 15 and 30 mg particulate respectively, while the rats in control group were only perfused with 1 ml normal saline. At the 2nd day after exposure to particulate, the rats in 3 dose groups were exposed to the mixed air of SO2 and NO2. The lower, middle, and higher dose group were exposed to mixed air of SO2 and NO2 at the concentrations as following: 8 and 5 mg/m3, 16 and 10 mg/m3, 32 and 20 mg/m3 respectively while the control group was exposed to fresh air two hour per day, continuously for 7 days. Half of the rats in each dose group were killed at the 1st day after the 7-day exposure to SO2 and NO2 , the rest were killed at the 8th day after the 7-day exposure to SO2 and NO2 . The contents of MDA, the activities of GST and SOD in serum, the activities of SOD and the contents of MDA in BALF were measured. Results At the 1st day after the exposure to SO2 and NO2 , lower activities of SOD and GST, and higher contents of MDA in serum of rats were observed in higher dose group compared with those in control group. At the 8th day after the exposure to SO2 and NO2 , significantly lower SOD activities were still observed in higher dose group compared with those in control group. It revealed that higher concentrations of air pollutants could decrease the activities of anti-oxidase and increase the contents of lipid peroxides in serum of rats. However, the SOD activities in BALF showed no significant differences among different dose groups at different time during the exposure period. Higher contents of MDA in BALF of rats were observed in higher dose group at the first day after the exposure to SO2 and NO2 , and in middle and higher dose group at the 8 th day after the exposure to SO2 and NO2 compared with those in control group (P

Objective To know the renal damage in cadmium (Cd) exposed residents in Cd polluted areas where polluted by Cd for 20 years. Methods The levels of urinary Cd (UCd), N-acetyl-beta-D-glucosaminidase (UNAG), ?2-microglobulin (UBMG), retinal binding protein (URBP), and albumin (UALB) were measured in 39, 65, 57, and 42 residents lived in the severe-, moderate-, light-, and non-polluted area respectively for more than 20 years. The test indexes were adjusted with urinary creatinine, and geometric means were statistically used. Results The levels of UCd in all subjects were obviously decreased compared with those in 1992, but the levels of UCd, UNAG, UBMG, and URBP and the abnormal rate of UNAG in residents in Cd-polluted areas were significantly higher than those in residents in non-polluted area (P

BACKGROUND: Foreign scholars use thermotherapy, a new pathway for synthetic therapy of tumor, to perform hyperpyrexia combined with chemical drug radiotherapy of intraperitoneal infiltration and metastasis or to study on the therapeutic effect of metaphase and advanced stage tumor. Especially, establishing thermal biology and thermal dosiology is a scientific and quantified track for synthetic therapy of thermal radiotherapy, thermal chemotherapy and hyperthermal perfusion of tumor.OBJECTIVE: To analyze the thermal dose effect of regional radiofrequency (RF) hyperthemia combined with radiotherapy, chemotherapy and thermal perfusion on metaphase and advanced stage tumor.DESIGN: Controlled observation.SETTING: Key Department of Traditional Chinese and Western Medicine for Tumor, the 107 Hospital of Chinese PLA (General Center for Non-traumatic Treatment and Diagnosis of Tumor).PARTICIPANTS: Totally 1 455 patients with metaphase and advanced-stage tumor admitted to the General Center for Non-traumatic Treatment and Diagnosis of Tumor, the 107 Hospital of Chinese PLA between June and September 2006 who received conservative palliative treatment in the Department of Internal Medicine were recruited in this study. They were all confirmed by pathology and imageology. ECOG was scored 2 to 4 points. Informed consents of detection and treatment were obtained from all the involved patients. The study was approved by the Hospital Ethics Committee.According to the therapeutic regimen, the patients were assigned into thermal perfusion group (n =53), thermal radiotherapy group (n =874), thermal chemotherapy group (n =458) and simple hyperthemia group (n =70).METHODS: After admission, patients in each group were performed peritoneal and pelvic cavity perfusion,intensity-modulated radiation therapy, routine chemotherapy and integrated traditional and western medicine palliative therapy, respectively. Meanwhile, they received RF hyperthemia using in vitro endogenic magnetic field hyperthermia system. A thermocouple was placed in the abdominal cavity. Temperature at 3 different sites in the abdominal cavity was collected, and meanwhile two different sites for measuring temperature at rectum and external acoustic meatus were monitored. The maximal temperature (Tmax), minimal temperature (Tmin) and the average temperature (Tave) of therapeutic target were recorded. 40 ℃/min was used as thermal dose, thermal perfusion was performed once a week, and RF hyperthemia was conducted twice a week, 60 minutes once. Target temperature was 39.5 to 43 ℃, and the thermal dose of 40 ℃/min was calculated out. Intensity-modulated radiation therapy was conducted within 1 hour before heating at (3-5)Gy/time, 3 to 4 times a week. Total dose was DT 30 to 50Gy. Thermal perfusion was conducted 2 to 3 times a week, and intensity-modulated radiation therapy was conducted once to twice a week and 6 to 8 times a course of treatment. The thermal effect of each patient was analyzed at different temperature and different diseases.MAIN OUTCOME MEASURES: ① To analyze the effect of effective thermal dose. ② To evaluate the therapeutic effect and the improvement of quality of life according to World Health Organization (WHO) objective therapeutic effect evaluation criteria and Zubrod-ECOG-WHO scores. ③To observe the changes in abdominal dropsy.RESULTS: Altogether 1 455 patients with metaphase and advanced stage participated in the final analysis. ①After perfusion, body temperature was over 39.5 ℃ in most cases after 15-minute warming, over 40.0 ℃ after another 25-minute warming, over 41.0 ℃ after additional 35-minute arming, and even to 43.0 ℃ after frequent such a thermal therapy. Temperature over 41 ℃ was found in 91 cases, at 40 ℃-40.9 ℃ in 414 cases and at 39.5 ℃-39.9 ℃ in 950 cases. ② The thermal effect of 40 ℃/min could obviously improve the therapeutic effects of graded intensity-modulated radiation therapy, low-dose chemotherapy and thermal perfusion group. The total effective rate of thermal perfusion group, thermal radiotherapy group, thermal chemotherapy group and simple hyperthemia group was 81.6%, 81.9%, 80% and 50%, respectively. The clinical therapeutic effect of 40 ℃-40.9 ℃ and 39.5 ℃-39.9 ℃ in the thermal perfusion group, thermal radiotherapy group and thermal chemotherapy group was significantly better than that in the simple hyperthemia group (P ＜ 0.05). ③ Comparison of Zubrod-ECOG-WHO score of patients before and after therapy: After therapy, Zubrod-ECOG-WHO score was enhanced in 76.3% patients. ④The changes in abdominal dropsy of patients before and after therapy: After therapy, abdominal dropsy changed in 75% patients.⑤The therapeutic effects of different diseases at different temperature: For the same disease, the therapeutic effects over 41 ℃ and at 40 ℃-40.9 ℃ were significantly different from those at 39.5 ℃-39.9 ℃(P ＜ 0.05); However, the therapeutic effects over 41 ℃ were not significantly different from those at 40 ℃-40.9 ℃ (P ＞ 0.05).CONCLUSION: ①The effects of regional RF hyperthemia combined with intensity-modulated radiation therapy are confirmed in the treatment of metaphase and advanced-stage of tumor. ② The therapeutic effects strengthen correspondingly with 40 ℃/min thermal dose increase or temperature increase.